NEU logo

NEU

NewMarket Corp

$752.37
-$21.45(-2.77%)
74
Overall
95
Value
72
Tech
55
Quality
Market Cap
$7.30B
Volume
94.18K
52W Range
$480.00 - $875.97
Target Price
$450.00

Company Overview

Mkt Cap$7.30BPrice$752.37
Volume94.18KChange-2.77%
P/E Ratio15.8Open$777.63
Revenue$2.8BPrev Close$773.82
Net Income$462.4M52W Range$480.00 - $875.97
Div Yield12.00%Target$450.00
Overall74Value95
Quality55Technical72

No chart data available

About NewMarket Corp

NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrain and hydraulic systems, gear oils, hydraulic oils, turbine oils, and other applications where metal-to-metal moving parts are utilized; engine oil additives designed for passenger cars, motorcycles, on and off-road heavy duty commercial equipment, locomotives, and engines in ocean-going vessels; driveline additives designed for products, such as transmission fluids, axle fluids, and off-road powertrain fluids; and industrial additives designed for products for industrial applications consisting of hydraulic fluids, greases, industrial gear fluids, and industrial specialty applications comprising turbine oils. It also provides fuel additives that are used to enhance the oil refining process and the performance of gasoline, diesel, biofuels, and other fuels to industry, government, original equipment manufacturers, and individual customers. In addition, the company engages in the marketing of antiknock compounds, as well as contracted manufacturing and related services; and owns and manages a real property in Virginia. It operates in North America, Latin America, the Asia Pacific, Europe, the Middle East, Africa, India, and internationally. NewMarket Corporation was founded in 1887 and is headquartered in Richmond, Virginia.

Sector: Basic Materials
Industry: Specialty Chemicals

Latest News

Neuren Pharmaceuticals Faces Delay in FDA Meeting for NNZ-2591

Neuren Pharmaceuticals Limited ( ($AU:NEU) ) has shared an update. Neuren Pharmaceuticals announced a one-month administrative delay in the FDA’s p...

TipRanks Australian Auto-Generated Newsdesk5 days ago

Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA)

Howard Kim9 days ago

Neuren Pharmaceuticals to Quote 150,000 New Securities on ASX

TipRanks Australian Auto-Generated Newsdesk20 days ago
ABCD
1SymbolPriceChangeVol
2NEU$752.37-2.8%94.18K
3
4
5
6

Get NewMarket Corp Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.